Disappearance of Clinical and Imaging Manifestations in Wilson's Disease with Ammonium Tetrathiomolybdate and Zinc.
作者信息
Posada Ignacio J, Ramos Ana
机构信息
Movement Disorders Unit, Department of Neurology University Hospital "12 de Octubre". Complutense University of Madrid Madrid Spain.
Department of Radiology University Hospital "12 de Octubre" Madrid Spain.
出版信息
Mov Disord Clin Pract. 2021 Nov 10;9(1):95-97. doi: 10.1002/mdc3.13359. eCollection 2022 Jan.
Abstract
摘要
相似文献
1
Disappearance of Clinical and Imaging Manifestations in Wilson's Disease with Ammonium Tetrathiomolybdate and Zinc.四硫代钼酸铵和锌治疗威尔逊病时临床及影像学表现的消失
Mov Disord Clin Pract. 2021 Nov 10;9(1):95-97. doi: 10.1002/mdc3.13359. eCollection 2022 Jan.
2
Practical recommendations and new therapies for Wilson's disease.威尔逊氏病的实用建议和新疗法
Drugs. 1995 Aug;50(2):240-9. doi: 10.2165/00003495-199550020-00004.
3
Pathophysiology and treatment of Wilson's disease.威尔逊氏病的病理生理学与治疗
Clin Pharm. 1991 Nov;10(11):839-49.
4
[Wilson's disease].[威尔逊氏病]
Acta Med Croatica. 2003;57(3):227-35.
5
Wilson's disease with hepatic presentation in childhood.儿童期以肝脏表现为主的威尔逊病。
Mymensingh Med J. 2007 Jan;16(1):29-32. doi: 10.3329/mmj.v16i1.244.
6
Use of zinc-copper metabolic interactions in the treatment of Wilson's disease.锌铜代谢相互作用在威尔逊病治疗中的应用。
J Am Coll Nutr. 1990 Oct;9(5):487-91. doi: 10.1080/07315724.1990.10720405.
7
Zinc and tetrathiomolybdate for the treatment of Wilson's disease and the potential efficacy of anticopper therapy in a wide variety of diseases.锌和四硫钼酸铵治疗威尔逊病和抗铜治疗在多种疾病中的潜在疗效。
Metallomics. 2009;1(3):199-206. doi: 10.1039/b901614g. Epub 2009 Apr 16.
8
[Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].[伴有严重神经症状的威尔逊病：对曲恩汀加锌治疗的反应]
Gastroenterol Hepatol. 2004 May;27(5):307-10. doi: 10.1016/s0210-5705(03)70465-8.
9
Wilson's disease: current status.威尔逊氏病：现状
Am J Med. 1992 Jun;92(6):643-54. doi: 10.1016/0002-9343(92)90783-8.
10
Initial therapy of patients with Wilson's disease with tetrathiomolybdate.用四硫代钼酸盐对威尔逊氏病患者进行初始治疗。
Arch Neurol. 1991 Jan;48(1):42-7. doi: 10.1001/archneur.1991.00530130050019.
本文引用的文献
1
Wilson Disease: An Overview and Approach to Management.威尔逊氏病：概述与管理方法
Neurol Clin. 2020 May;38(2):417-432. doi: 10.1016/j.ncl.2020.01.005. Epub 2020 Feb 28.
2
Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series.四硫钼酸铵在伴有神经症状的威尔逊病去铜阶段治疗中的应用：病例系列。
Brain Behav. 2020 May;10(5):e01596. doi: 10.1002/brb3.1596. Epub 2020 Mar 22.
3
Advances in Treatment of Wilson Disease.肝豆状核变性的治疗进展
Tremor Other Hyperkinet Mov (N Y). 2018 Feb 28;8:525. doi: 10.7916/D841881D. eCollection 2018.
4
Clinical considerations for an effective medical therapy in Wilson's disease.Wilson 病有效医学治疗的临床考虑。
Ann N Y Acad Sci. 2014 May;1315:81-5. doi: 10.1111/nyas.12437. Epub 2014 Apr 22.
5
A novel Global Assessment Scale for Wilson's Disease (GAS for WD).一种新型的肝豆状核变性全球评估量表（WD的GAS）。
Mov Disord. 2009 Mar 15;24(4):509-18. doi: 10.1002/mds.22231.
6
Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy.用四硫代钼酸铵治疗威尔逊病：III. 55例神经受累患者的初始治疗及锌剂治疗随访
Arch Neurol. 2003 Mar;60(3):379-85. doi: 10.1001/archneur.60.3.379.
7
Use of ammonium tetrathiomolybdate in the treatment of copper poisoning in sheep.四硫代钼酸铵在绵羊铜中毒治疗中的应用。
Vet Rec. 1986 Dec 13;119(24):596-8.
Zotero 插件